Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation.
about
Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments.USIDNET: a strategy to build a community of clinical immunologists.Economic impact of infections among patients with primary immunodeficiency disease receiving IVIG therapy.Initiation of immunoglobulin therapy by subcutaneous administration in immunodeficiency patients naive to replacement therapyBAY 41-2272 activates host defence against local and disseminated Candida albicans infections.Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs.A Novel Targeted Screening Tool for Hypogammaglobulinemia: Measurement of Serum Immunoglobulin (IgG, IgM, IgA) Levels from Dried Blood Spots (Ig-DBS Assay).Clinical predictors of primary immunodeficiency diseases in children.Comprehensive screening for immunodeficiency-associated vaccine-derived poliovirus: an essential oral poliovirus vaccine cessation risk management strategy.The spread of the J Project.Important differences in the diagnostic spectrum of primary immunodeficiency in adults versus children.Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery.Report of the Tunisian Registry of Primary Immunodeficiencies: 25-Years of Experience (1988-2012).Life with a Primary Immune Deficiency: a Systematic Synthesis of the Literature and Proposed Research Agenda.Modeling strategy to identify patients with primary immunodeficiency utilizing risk management and outcome measurement.Switching Patients to Home-Based Subcutaneous Immunoglobulin: an Economic Evaluation of an Interprofessional Drug Therapy Management Program.Primary immunodeficiencies worldwide: an updated overview from the Jeffrey Modell Centers Global Network.Disseminated bronchiectasis in an adult with common variable immunodeficiency.Invasive meningococcal disease in three siblings with hereditary deficiency of the 8(th) component of complement: evidence for the importance of an early diagnosisThe effects of prenatal genetic analysis on fetuses born to carrier mothers with primary immunodeficiency diseases.Ensuring Access to Immunoglobulin Therapies for People with Primary Immunodeficiency: A Need to Improve Individuals' Quality of Life and the Sustainability of Health-care Systems.Poliovirus excretion among persons with primary immune deficiency disorders: summary of a seven-country study series.Specific antibody deficiency in children with recurrent respiratory infections: a controlled study with follow-up.Common variable immunodeficiency and natural killer cell lymphopenia caused by Ets-binding site mutation in the IL-2 receptor γ (IL2RG) gene promoter.Prioritization of evidence-based indications for intravenous immunoglobulin.Primary immunodeficiency diseases in children: 15 year experience in a tertiary care medical center in Qatar.An analysis and decision tool to measure cost benefit of newborn screening for severe combined immunodeficiency (SCID) and related T-cell lymphopenia.Modeling primary immunodeficiency disease epidemiology and its treatment to estimate latent therapeutic demand for immunoglobulin.The prevalences [correction] and patient characteristics of primary immunodeficiency diseases in Turkey--two centers study.Primary Immunodeficiency Diseases: Need for Awareness and Advocacy in India.Health-related quality of life (HRQL) in immunodeficient adults with selective IgA deficiency compared with age- and gender-matched controls and identification of risk factors for poor HRQL.Primary immunodeficiency diseases worldwide: more common than generally thought.Clinical and economic outcomes of a "high-touch" clinical management program for intravenous immunoglobulin therapy.Economic burden of common variable immunodeficiency: annual cost of disease.Primary immunodeficiency diseases in lung disease: warning signs, diagnosis and managementThe burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data
P2860
Q33415221-840DCC59-EC1D-473B-BD46-6770FFE03803Q33716493-38014255-8BC2-4A93-9078-428F66825F08Q33769363-330F0F40-A89B-48C3-A934-4B88FA30462EQ34753641-2F1064E2-BA02-474B-B005-EA97AD1A738DQ35210863-F190D39F-B6D7-456A-8434-9852CC0925F5Q35779733-3ED7B1B6-33C2-4253-BE37-E556CCDD7CCFQ36065390-CB555B27-344C-4BD1-A091-C104B7D0FFE1Q36628771-549E901C-FE7F-4272-A05F-BC7E94210E8CQ37542082-738823EC-A880-408D-81C6-9DC9EC7C0638Q38107841-FC6B1F44-1DB4-480D-9797-B22CE20152CBQ38306637-F7E4DE65-8414-4EC0-93A1-88F6BABFDC34Q38398798-D3BB84D2-6296-4E84-B8EC-9F97B0DEAC1AQ38606561-F8CE6FB3-ABEE-48F4-80A1-D3540A4C40A2Q38731981-34635101-D227-465C-9A38-1590A64E0E66Q38948860-39A76674-096D-4526-BA40-7D0CC36423DBQ39799989-1FC55F91-5FD7-4AAA-8465-4B2E27153709Q40070985-A07E6888-6B19-495A-9FBD-0692A2F683FEQ40154117-A9FE487E-8F57-482C-9A25-9B508E2818B0Q40672986-746FA6F5-6487-4402-8D6E-D98B6FB811EFQ40800083-8968E2F3-AB17-4F28-BD03-3061A056EBC4Q41810269-7CC473D6-D948-43AA-9E13-AB2F13EBA95EQ42183588-7CD5455E-4921-4F66-8025-86F163D63A11Q42267321-C4306ECB-9364-49AB-B72C-2F0C75FF4316Q42624016-D5F21B70-53AD-4578-9C02-DEB60D1F5B51Q43103915-0DC3ADFF-A41C-4055-B752-31069937CB91Q43805784-90561D81-752E-44E7-94A5-2F7970778CCEQ44830662-446AF33C-F4FB-4998-BE01-FD21B72C27E4Q44871560-E720C4AE-1294-4C36-8A0D-A7B9B7C27574Q44885671-E2C8CA12-6892-489A-9D99-554B70B4EF7BQ45210860-4DB7F0CA-207E-4ECC-87FE-A86BA2027B0CQ46347635-BE9DE0A0-E91C-4599-AE46-34D08A2AD582Q46387851-61FBDAD6-E42F-476A-AF28-EEE3319379B3Q47217747-5966E54F-63BF-49E1-9601-8CD3D23177F2Q51276222-0F8E233F-8E07-4A07-963E-0B3EF257AC7AQ59127411-884B3116-3610-42B2-9ADD-39D638BE7076Q59136202-DA106B1A-90BE-485A-91B7-DC924908EEA0
P2860
Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Global study of primary immuno ...... the Jeffrey Modell Foundation.
@en
type
label
Global study of primary immuno ...... the Jeffrey Modell Foundation.
@en
prefLabel
Global study of primary immuno ...... the Jeffrey Modell Foundation.
@en
P2093
P2860
P1433
P1476
Global study of primary immuno ...... the Jeffrey Modell Foundation
@en
P2093
Bonnie Gee
Chaim M Roifman
David B Lewis
Fred Modell
John M Routes
Luigi D Notarangelo
Ricardo U Sorensen
Vicki Modell
P2860
P2888
P356
10.1007/S12026-011-8241-Y
P577
2011-10-01T00:00:00Z
P5875
P6179
1007224825